EPISODE · Jul 1, 2025 · 15 MIN
Targeted Therapy for Colorectal Cancer: How Personalized Treatments Are Changing Outcomes
In this episode, we explore how targeted therapy is transforming colorectal cancer care, offering patients more effective, personalized options that go beyond traditional chemotherapy.You’ll learn:How targeted therapies work to disrupt cancer cell growth while sparing healthy cellsWhy genes like KRAS, BRAF, and MSI status are critical for tailoring treatmentsThe role of anti-VEGF and anti-EGFR therapies in controlling advanced tumorsWhat to know about resistance and the future of combination treatment strategiesHow immunotherapy is opening new doors for MSI-high colorectal cancersThe importance of clinical trials in expanding targeted therapy optionsWhether you’re newly diagnosed or seeking advanced treatment options, this episode highlights the breakthroughs giving new hope to colorectal cancer patients, especially when standard treatments no longer work.Blog Link: Targeted Therapy for Colorectal CancerSend us Fan MailThank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.Author: Dr. CHRISTINA NG VAN TZE📍 Visit us at oncolifecentre.com 📞 Call: +603-2242-2620 📧 Book a consultation or ask a question — we're here to support your journey.
What this episode covers
In this episode, we explore how targeted therapy is transforming colorectal cancer care, offering patients more effective, personalized options that go beyond traditional chemotherapy. You’ll learn: How targeted therapies work to disrupt cancer cell growth while sparing healthy cellsWhy genes like KRAS, BRAF, and MSI status are critical for tailoring treatmentsThe role of anti-VEGF and anti-EGFR therapies in controlling advanced tumorsWhat to know about resistance and the future of combinatio...
NOW PLAYING
Targeted Therapy for Colorectal Cancer: How Personalized Treatments Are Changing Outcomes
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m